| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. | Director | Common Stock | 22.3K | $22.7K | $1.02 | 12 Dec 2025 | Direct |
| PharmaCyte Biotech, Inc. | Director | Common Stock | 800 | $680 | $0.85 | 25 Apr 2025 | By Transplant Consulting LLC |
| PharmaCyte Biotech, Inc. | Director | Stock Option (Right to Buy) | 63.2K | 25 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PMCB | PharmaCyte Biotech, Inc. | 25 Apr 2025 | 3 | -$17.2K | 4 | Director | 12 Dec 2025, 17:06 |
| PMCB | PharmaCyte Biotech, Inc. | 30 Apr 2024 | 1 | $0 | 4 | Director | 17 Jul 2024, 16:58 |
| PMCB | PharmaCyte Biotech, Inc. | 20 Nov 2023 | 1 | $0 | 4 | Director | 22 Nov 2023, 17:00 |
| PMCB | PharmaCyte Biotech, Inc. | 10 Aug 2021 | 0 | $0 | 3 | Director | 20 Aug 2021, 20:35 |